Clinical Trials
6
Active:4
Completed:0
Trial Phases
2 Phases
Phase 1:3
Phase 3:2
Drug Approvals
1
FDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (60.0%)Phase 3
2 (40.0%)Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy
Recruiting
- Conditions
- Peripheral Diabetic NeuropathyPainful Diabetic Neuropathy
- Interventions
- First Posted Date
- 2024-07-10
- Last Posted Date
- 2025-07-25
- Lead Sponsor
- Averitas Pharma, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT06495424
- Locations
- 🇺🇸
Pacific Research Institute, Sonoma, California, United States
🇺🇸Center for Interventional Pain and Spine, Lancaster, Pennsylvania, United States
🇺🇸Horizon Clinical Research, Newnan, Georgia, United States
Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery
Phase 3
Active, not recruiting
- Conditions
- Post Surgical Neuropathic Pain
- Interventions
- First Posted Date
- 2021-07-19
- Last Posted Date
- 2025-07-23
- Lead Sponsor
- Averitas Pharma, Inc.
- Target Recruit Count
- 409
- Registration Number
- NCT04967664
- Locations
- 🇺🇸
Tucson Orthopaedic Institute, Tucson, Arizona, United States
🇺🇸UCSD Center for Pain Medicine, La Jolla, California, United States
🇺🇸ILD Research Center, Vista, California, United States
News
No news found